Are New Riches In Store For Superstars Of Research? If Some Current Trends Continue, The Answer Is Yes!

A news story you might be reading in 2003: LOS ANGELES--A bidding war broke out yesterday for the rights to publish a scientific study identifying a master gene that con~trols aging. In the end, the journal Genes & Proteins topped offers from four other journals and agreed to pay the authors of the breakthrough paper $137,000--a new record for a scientific paper sold at auction. "With this money, we'll be able to hire a couple of postdocs, and that will help speed up the work in our lab," R

Written byDavid Pendlebury
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

LOS ANGELES--A bidding war broke out yesterday for the rights to publish a scientific study identifying a master gene that con~trols aging. In the end, the journal Genes & Proteins topped offers from four other journals and agreed to pay the authors of the breakthrough paper $137,000--a new record for a scientific paper sold at auction.

"With this money, we'll be able to hire a couple of postdocs, and that will help speed up the work in our lab," Robert Kildow, director of the Phoenix Institute for the Study of Cell Senescence in Arizona, told reporters immediately after the winning bid was accepted.

By late in the day, word of the record price had swept through the scientific community, rais~ing hopes of many researchers whose papers are coming up for auction next month

The practice of paying authors for the rights to publish their hottest ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies